Javascript must be enabled to continue!
Recent advances in the pathology of pituitary adenomas
View through CrossRef
Abstract
Introduction: Pituitary adenomas are the third most common intracranial tumours. The 2004 WHO classification of pituitary adenomas has recommended the use of immunohistochemistry, electron microscopy and molecular techniques along with clinical and morphological evaluation in making a diagnosis. This review examines the subtypes of pituitary adenomas seen using the different diagnostic techniques. Materials and Methods: A comprehensive search of literature as well as an online search of databases was made. Results: The classification and molecular properties of the different subclasses are highlighted in this review. Pituitary adenomas are among the most frequent intracranial tumours and can present with over-expression of the hormones normally produced by the pituitary gland or pressure symptoms from the tumour. Pituitary adenomas are clonal tumours and often show over-expression of tumour suppressor genes which can sometimes be familial. Molecular studies have shown expression of common genes that can be employed to group pituitary adenomas based on their histogenetic origin. These genetic properties can be helpful in delineating those tumours which do not show clear cut lineage. This is particularly useful in the assessment of silent and plurihormonal adenomas. Several subclasses exist and the presentation may be different depending on the particular hormone produced. The prolactinomas are the commonest type followed by the silent adenomas with Gonadotroph and TSH producing adenomas constituting the rare types. Conclusion. Pituitary carcinomas are rare tumours diagnosed only in the presence of metastatic deposits in other tissues.
The Brazilian Society of Anatomy (SBA)
Title: Recent advances in the pathology of pituitary adenomas
Description:
Abstract
Introduction: Pituitary adenomas are the third most common intracranial tumours.
The 2004 WHO classification of pituitary adenomas has recommended the use of immunohistochemistry, electron microscopy and molecular techniques along with clinical and morphological evaluation in making a diagnosis.
This review examines the subtypes of pituitary adenomas seen using the different diagnostic techniques.
Materials and Methods: A comprehensive search of literature as well as an online search of databases was made.
Results: The classification and molecular properties of the different subclasses are highlighted in this review.
Pituitary adenomas are among the most frequent intracranial tumours and can present with over-expression of the hormones normally produced by the pituitary gland or pressure symptoms from the tumour.
Pituitary adenomas are clonal tumours and often show over-expression of tumour suppressor genes which can sometimes be familial.
Molecular studies have shown expression of common genes that can be employed to group pituitary adenomas based on their histogenetic origin.
These genetic properties can be helpful in delineating those tumours which do not show clear cut lineage.
This is particularly useful in the assessment of silent and plurihormonal adenomas.
Several subclasses exist and the presentation may be different depending on the particular hormone produced.
The prolactinomas are the commonest type followed by the silent adenomas with Gonadotroph and TSH producing adenomas constituting the rare types.
Conclusion.
Pituitary carcinomas are rare tumours diagnosed only in the presence of metastatic deposits in other tissues.
Related Results
Neuroimaging Assessment of Aggressive Pituitary Adenomas
Neuroimaging Assessment of Aggressive Pituitary Adenomas
Aggressive pituitary adenomas (APA) are adenomas that show rapid growth, invasiveness, frequent or multiple relapses, or are resistant to conventional therapies. Clinical-imaging a...
Metallothionein Isoform 3 Gene Is Differentially Expressed in Corticotropin-Producing Pituitary Adenomas
Metallothionein Isoform 3 Gene Is Differentially Expressed in Corticotropin-Producing Pituitary Adenomas
In order to search for candidate genes related to pituitary adenoma aggressiveness, the present investigation was intended to compare the mRNA expression profile from a pool of fou...
Plurihormonal pituitary macroadenoma: a case report
Plurihormonal pituitary macroadenoma: a case report
Abstract
Background
Plurihormonal pituitary adenomas are a unique type of pituitary adenomas that secrete two or more pituitary hormones normally as...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
COVID-19 induced hypercoagulability and its impact leading to pituitary apoplexy
COVID-19 induced hypercoagulability and its impact leading to pituitary apoplexy
I am writing this letter to address an increasingly high-risk but under-explored complication of pituitary apoplexy in patients who have contracted COVID-19. In light of recent res...
Growth Hormone (GH) Deficiency (GHD) of Childhood Onset: Reassessment of GH Status and Evaluation of the Predictive Criteria for Permanent GHD in Young Adults
Growth Hormone (GH) Deficiency (GHD) of Childhood Onset: Reassessment of GH Status and Evaluation of the Predictive Criteria for Permanent GHD in Young Adults
GH secretion was reevaluated after completion of GH treatment at a mean age of 19.2 ± 3.2 yr in 35 young adults with childhood-onset GH deficiency (GHD). The patients were subdivid...
Clinically Functioning FSH-Secreting Pituitary Adenoma
Clinically Functioning FSH-Secreting Pituitary Adenoma
Abstract
Background: Gonadotroph adenomas are the most common type of non-functioning pituitary adenomas. However functioning gonadotroph adenomas are rare with only...
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas
SummaryObjective BRAF is an oncogene that is commonly mutated in both melanomas and papillary thyroid carcinomas, usually at position V600E that leads to constitutive activity in...

